Not Medicare Enrolled

Dr. Marc Sharfman, M.D.

Q: Does Dr. Sharfman receive payments from pharmaceutical companies?

Yes. Dr. Sharfman received a total of $260,096 from 18 companies across 581 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.

Q: What does Data Coverage mean?

Data Coverage (currently Moderate for Dr. Sharfman) measures how much public federal data is available about a provider. It is not a quality rating. A Very High or High level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A Low or Moderate level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative.

Neurology · Longwood, FL

2137 W STATE ROAD 434, Longwood, FL 32779

4076443737

Registered in NPPES since 2005

NPI: 1750376364 verify on NPPES ↗

Moderate

DATA COVERAGE

Data in 2 of 4 federal sources

Measures public federal data availability — not provider quality

Informational, not a quality rating. This page presents federal public records about Dr. Sharfman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →

Are you Dr. Sharfman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sharfman

Dr. Marc Sharfman is a neurology specialist in Longwood, FL, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Sharfman received a total of $260,096 from 18 pharmaceutical and/or device companies across 581 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sharfman is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration $260,096 industry payments

Florida License Status

FL DOH · MQA

Active license

None

Board action on record

Recent admin complaints

Profession	License #	Status	Expires	Board Action
Medical Doctor	59331	Clear	January 31, 2027	—

Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Industry Payment Transparency

Open Payments through 2024 ↗

$260,096

Total received (2018-2024)

Avg $37,156/year across 7 years

Top 2% in FL for neurology

A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.

Companies

581

Payment records

Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024

$12,582

2023

$18,049

2022

$49,762

2021

$28,502

2020

$14,850

2019

$66,913

2018

$69,437

Payments by company (2024)

ABBVIE INC.

$12,405

PFIZER INC.

$135

Lilly USA, LLC

$42

Top 3 companies account for 100.0% of 2024 payments

All-time payments by company (2018-2024) ›

Amgen Inc.

$107,302

ABBVIE INC.

$45,477

AbbVie Inc.

$40,130

Teva Pharmaceuticals USA, Inc.

$23,854

Allergan, Inc.

$12,438

Assertio Therapeutics, Inc.

$12,047

Lilly USA, LLC

$10,293

Avanir Pharmaceuticals, Inc.

$6,152

Promius Pharma LLC

$1,614

PFIZER INC.

$276

Biohaven Pharmaceuticals, Inc.

$145

Biohaven Pharmaceutical Holding Company Ltd.

$102

Novartis Pharmaceuticals Corporation

$87

Bausch Health US, LLC

$80

Upsher-Smith Laboratories LLC

$47

Scilex Pharmaceuticals Inc.

$20

ASSERTIO THERAPEUTICS, Inc.

$18

Egalet US Inc

$14

Top 3 companies account for 74.2% of all-time payments

Associated products mentioned in payments ›

AIMOVIG · AJOVY · AUSTEDO · Aimovig · BOTOX · CAMBIA · COPAXONE · Cambia · EMGALITY · LYRICA · MIGRANAL · NUEDEXTA · NURTEC ODT · ONZETRA · ONZETRA Xsail · PAXLOVID · QULIPTA · SPRIX · TOSYMRA SUMATRIPTAN NASAL SPRAY · UBRELVY · ZTLido · Zembrace · Zembrace SymTouch Sumatriptan Injection

Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Looking for a neurology specialist in Longwood?
Compare neurologists in the Longwood area by procedure volume, costs, and industry payment transparency.

Browse neurologists nearby

Geographic Context

Neurologists in nearby ZIP areas

County median income

$83,030

Nearest hospital to ZIP centroid (approximate)

CENTRAL FLORIDA LAKE MONROE HOSPITAL
8.5 mi

Data Sources

Provider Registry	✓ NPPES	NPPES snapshot; verify current record
Medicare Enrollment	— Not enrolled	N/A
Practice Data	— No data	N/A
Industry Payments	✓ Open Payments	CY 2024
Disciplinary History	— Not included	N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Sharfman is a neurology specialist, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Sharfman receive payments from pharmaceutical companies?

Yes. Dr. Sharfman received a total of $260,096 from 18 companies across 581 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.

What does Data Coverage mean?

Data Coverage (currently Moderate for Dr. Sharfman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →

Is this data up to date?

Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Specialty guide

Understanding Neurology

Common procedures, typical costs, and what industry payments mean in neurology.

Same specialty & city

Neurologists in Longwood

Browse neurologists in Longwood ranked by procedure volume and transparency data.

Highest volume

Top Neurologists in FL

Neurologists ranked by total Medicare services performed statewide.

Industry payments

Pharma Payments to Neurologists in FL

Which FL neurologists receive the most from drug and device companies.

By company

Amgen Inc. Payments to Doctors

See all physicians who received payments from Amgen Inc.

By company

ABBVIE INC. Payments to Doctors

See all physicians who received payments from ABBVIE INC.

By company

AbbVie Inc. Payments to Doctors

See all physicians who received payments from AbbVie Inc.

About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology